Literature DB >> 15777790

Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines.

Beatrice E Bachmeier1, Adriana Albini, Roberta Vené, Roberto Benelli, Douglas Noonan, Cora Weigert, Christoph Weiler, Ralf Lichtinghagen, Marianne Jochum, Andreas G Nerlich.   

Abstract

Matrix metalloproteinases (MMPs) play a key role in cellular invasion and growth. Recent observations on tumor tissue samples suggest that MMP activity is altered in relation to cell density. Therefore, we examined MMP(-1,-2,-3,-8,-9,-10,-11 and -13) and TIMP-1/-2 expression of well-defined cell densities in breast carcinoma cell lines with differing in vivo tumorigenicity/invasiveness (MCF-7 < MDA-MB-468 < MDA-MB-231 < MDA-MB-435). Chemoinvasion assays were performed to link the in vitro data to the in vivo behavior. In accord with previous in vivo data, expression levels of most MMPs decreased significantly with increasing cell density and correlated well with a lower in vitro invasiveness of confluent cells. Since these data suggested that cell density regulates transcription and the promoter regions of most MMPs have AP-1 transcription factor binding consensus sequences, we tested whether functional AP-1 protein was involved in the mechanism of MMP downregulation by cell density. A role for AP-1 was confirmed by over-expression of c-Jun and c-fos in confluent MDA-MB-231 cells, showing with c-Jun increased MMP-2 (5-fold), MMP-3 (1.6-fold), and MMP-9 (160-fold) expression, as well as enhanced invasive potential, while TIMP-1 expression was down-regulated (2-fold) when compared to vector controls. Our data provide clear evidence that cell density regulates major MMPs and TIMPs which are controlled by AP-1 activity so that ultimately a major regulation pathway for the control of the invasive potential of tumor cells is presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777790     DOI: 10.1016/j.yexcr.2004.12.019

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells.

Authors:  Maria Buoncervello; Paola Borghi; Giulia Romagnoli; Francesca Spadaro; Filippo Belardelli; Elena Toschi; Lucia Gabriele
Journal:  Neoplasia       Date:  2012-09       Impact factor: 5.715

2.  Profiling of Multiple Matrix Metalloproteinases Activities in the Progression of Osteosarcoma by Peptide Microarray-Based Fluorescence Assay on Polymer Brush-Coated Zinc Oxide Nanorod Substrate.

Authors:  Zhenxin Wang; Minghong Jian; Xiaotong Li
Journal:  Methods Mol Biol       Date:  2023

3.  Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.

Authors:  Diala El Khoury; Damien Destouches; Renée Lengagne; Bernard Krust; Yamina Hamma-Kourbali; Marylène Garcette; Sandra Niro; Masashi Kato; Jean-Paul Briand; José Courty; Ara G Hovanessian; Armelle Prévost-Blondel
Journal:  BMC Cancer       Date:  2010-06-24       Impact factor: 4.430

4.  Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration.

Authors:  Beatrice E Bachmeier; Andreas Nerlich; Norbert Mittermaier; Christoph Weiler; Christianto Lumenta; Karin Wuertz; Norbert Boos
Journal:  Eur Spine J       Date:  2009-05-23       Impact factor: 3.134

5.  Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells.

Authors:  Beatrice Bachmeier; Iduna Fichtner; Peter H Killian; Emanuel Kronski; Ulrich Pfeffer; Thomas Efferth
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

6.  Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type.

Authors:  Bernard Krust; Diala El Khoury; Isabelle Nondier; Calaiselvy Soundaramourty; Ara G Hovanessian
Journal:  BMC Cancer       Date:  2011-08-03       Impact factor: 4.430

7.  TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.

Authors:  Luciana R Gomes; Letícia F Terra; Rosângela Am Wailemann; Leticia Labriola; Mari C Sogayar
Journal:  BMC Cancer       Date:  2012-01-19       Impact factor: 4.430

8.  c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.

Authors:  S S Ganguly; L S Fiore; J T Sims; J W Friend; D Srinivasan; M A Thacker; M L Cibull; C Wang; M Novak; D M Kaetzel; R Plattner
Journal:  Oncogene       Date:  2011-09-05       Impact factor: 9.867

9.  Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

Authors:  Rita C S Figueira; Luciana R Gomes; João S Neto; Fabricio C Silva; Ismael D C G Silva; Mari C Sogayar
Journal:  BMC Cancer       Date:  2009-01-14       Impact factor: 4.430

10.  Density-dependent lineage instability of MDA-MB-435 breast cancer cells.

Authors:  Andreas G Nerlich; Beatrice E Bachmeier
Journal:  Oncol Lett       Date:  2013-01-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.